Clinical Trials Browser

Gastritis, Atrophic, Gastrointestinal Neoplasms, Influenza, Human, Liver Cirrhosis, Liver Neoplasms, Pancreatic Neoplasms, Peptic Ulcer, Stomach Neoplasms, Tuberculosis, Colorectal Neoplasms, Inflammatory Bowel Diseases, Pancreatitis, Chronic

NCT03577808 2018-08-20

Organoids in Predicting Chemoradiation Sensitivity on Rectal Cancer

Unknown

80 enrolled

Gastrointestinal

Rectal Neoplasms

NCT02480933 2017-11-28

SISYPHUS

Phase NA Unknown

768 enrolled

Breast

Breast Neoplasms, Male

NCT02625337 2017-09-15

IMPemBra

Phase 2 Unknown

32 enrolled

Dermatologic

Melanoma

NCT02894853 2017-09-14

LEMA

Unknown

1,297 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03174054 2017-06-02

The Value of PSMA-PET Compared With Multi-parametric MRI in the Detection Prostate Lesions

Unknown

70 enrolled

Genitourinary

Prostatic Neoplasms

NCT03140007 2017-05-08

Cholangioscopy

Phase NA Unknown

60 enrolled

Gastrointestinal

Cholangiocarcinoma

NCT02938728 2016-10-25

PREDIMEL

Unknown

120 enrolled

Dermatologic

Melanoma

NCT02931981 2016-10-13

Serum Dickkopf-4 as a Biomarker for the Diagnosis and Treatment of Gastrointestinal Stromal Tumor

Unknown

50 enrolled

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT02898857 2016-09-13

NOTCH

Unknown

18 enrolled

Thoracic

Adenocarcinoma of Lung

NCT02406924 2015-04-02

PaMP

Phase NA Unknown

24 enrolled

Genitourinary

Prostatic Intraepithelial Neoplasia

NCT00415298 2014-01-10

AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck Cancer

Phase NA Unknown

12 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00553124 2014-01-10

Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer

Phase 3 Unknown

3,400 enrolled

Genitourinary

Urinary Bladder Neoplasms

Clinical Trials

Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines

Inflammatory Index as a Predictor for Endometrial Cancer: an Observational Study

CERTIFIKO

MTTRIHPW

The Bacterial Composition of the Stomach in Reflux Disease

Histopathological Changes in Mycosis Fungoides

Skin Tumor Biomarkers by Mass Spectrometry Imaging

Study of the Role of Oncostatin M in Head and Neck Squamous Cell Carcinoma

OpACIN-neo

OSIRIS

Fusobacterium Nucleatum at Colorectal Cancer Sites

PIONeeR

Melamoma4p

Bitter Taste Receptors in Oropharynx Cancer

COLATA

Oncologic Safety of Sentinel Lymph Node Biopsy in Clinically Palpable Axillary Lymph Node in Breast Cancer Patients

[68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid Tumors

MITOSKIN

HERdi PREDICT

ProstaPilot

Clinical Characters and Outcome of Acute Myeloid Leukemia Patients on Correlation to CD200 and CD56 Expression

Correlation of Metabolic Imaging With Immune Markers in NSCLC Candidate to Immunotherapy.

Study on the Value of Non-invasive Dual-Pet Information in Subtype of Metastatic Breast Cancer

Single-cell Sequencing and Establishment of Models in Neuroendocrine Neoplasm

MYOSARC

Neuroendocrine Neoplasm Based on Multi-omics Integrated Analysis

Pancreatic Cancer Models Developed From EUS Guided Biopsy Tissue

PROMPT

IMPACNEO

OPT-1

BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics

Drug Screening of Pancreatic Cancer Organoids Developed From EUS-FNA Guided Biopsy Tissues

Breast Ultrasound Image Reviewed With Assistance of Deep Learning Algorithms

The Role of ctDNA and PBMC in Treatment of Biliary Tract Cancer

Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients

The IGF Axis Involvement in Immune Tumor Microenvironment in Ovarian Cancer and Its Clinical Significance

TCR

Volatolome

Organoids in Predicting Chemoradiation Sensitivity on Rectal Cancer

SISYPHUS

IMPemBra

LEMA

The Value of PSMA-PET Compared With Multi-parametric MRI in the Detection Prostate Lesions

Cholangioscopy

PREDIMEL

Serum Dickkopf-4 as a Biomarker for the Diagnosis and Treatment of Gastrointestinal Stromal Tumor

NOTCH

PaMP

AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck Cancer

Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer